US Stock MarketDetailed Quotes

KZR Kezar Life Sciences

Watchlist
  • 6.280
  • -0.010-0.16%
Trading Dec 19 09:42 ET
45.82MMarket Cap-0.48P/E (TTM)

Kezar Life Sciences Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Total revenue
0
0
0
7M
0
7M
0
0
0
0
Operating revenue
--0
--0
--0
--7M
--0
--7M
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
-32.52%21.95M
-18.23%21.9M
-3.32%23.71M
57.72%112.24M
41.77%28.4M
71.86%32.53M
64.09%26.78M
54.45%24.52M
30.19%71.16M
42.05%20.03M
Selling and administrative expenses
-35.08%5.71M
-3.15%5.6M
5.37%6.54M
31.69%26.54M
11.30%5.76M
73.46%8.79M
16.23%5.79M
25.78%6.21M
28.17%20.15M
19.74%5.18M
-General and administrative expense
-35.08%5.71M
-3.15%5.6M
5.37%6.54M
31.69%26.54M
11.30%5.76M
73.46%8.79M
16.23%5.79M
25.78%6.21M
28.17%20.15M
19.74%5.18M
Research and development costs
-31.58%16.24M
-22.39%16.3M
-6.26%17.17M
68.00%85.7M
52.38%22.64M
71.27%23.74M
85.08%21M
67.38%18.32M
31.01%51.01M
51.92%14.86M
Operating profit
14.02%-21.95M
18.23%-21.9M
3.32%-23.71M
-47.88%-105.24M
-41.77%-28.4M
-34.87%-25.53M
-64.09%-26.78M
-54.45%-24.52M
-30.19%-71.16M
-42.05%-20.03M
Net non-operating interest income expense
-32.55%1.64M
-25.85%1.84M
-11.70%2.05M
226.86%9.55M
25.69%2.33M
124.44%2.42M
1,720.59%2.48M
1,692.47%2.33M
9,979.31%2.92M
1,800.00%1.85M
Non-operating interest income
-27.73%2.04M
-21.81%2.24M
-8.98%2.45M
170.30%11.1M
23.89%2.73M
102.88%2.82M
601.23%2.86M
2,395.37%2.7M
2,085.11%4.11M
4,304.00%2.2M
Non-operating interest expense
1.77%403K
4.16%401K
8.11%400K
30.80%1.55M
14.33%399K
27.74%396K
41.54%385K
45.67%370K
645.28%1.19M
119.50%349K
Other net income (expense)
-1.48M
-6.19M
Special income (charges)
--0
---1.48M
----
---6.19M
---6.19M
--0
--0
----
--0
----
-Less:Restructuring and merger&acquisition
--0
--1.48M
----
--6.19M
--6.19M
--0
--0
----
--0
----
Income before tax
12.08%-20.31M
11.36%-21.55M
2.44%-21.66M
-49.28%-101.87M
-77.44%-32.26M
-29.45%-23.1M
-50.17%-24.31M
-38.54%-22.2M
-24.91%-68.24M
-27.93%-18.18M
Income tax
Net income
12.08%-20.31M
11.36%-21.55M
2.44%-21.66M
-49.28%-101.87M
-77.44%-32.26M
-29.45%-23.1M
-50.17%-24.31M
-38.54%-22.2M
-24.91%-68.24M
-27.93%-18.18M
Net income continuous Operations
12.08%-20.31M
11.36%-21.55M
2.44%-21.66M
-49.28%-101.87M
-77.44%-32.26M
-29.45%-23.1M
-50.17%-24.31M
-38.54%-22.2M
-24.91%-68.24M
-27.93%-18.18M
Minority interest income
Net income attributable to the parent company
12.08%-20.31M
11.36%-21.55M
2.44%-21.66M
-49.28%-101.87M
-77.44%-32.26M
-29.45%-23.1M
-50.17%-24.31M
-38.54%-22.2M
-24.91%-68.24M
-27.93%-18.18M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
12.08%-20.31M
11.36%-21.55M
2.44%-21.66M
-49.28%-101.87M
-77.44%-32.26M
-29.45%-23.1M
-50.17%-24.31M
-38.54%-22.2M
-24.91%-68.24M
-27.93%-18.18M
Basic earnings per share
12.58%-2.78
11.76%-3
3.23%-3
-38.61%-14
-76.00%-4.4
-27.20%-3.18
-36.00%-3.4
-19.23%-3.1
2.88%-10.1
0.00%-2.5
Diluted earnings per share
12.58%-2.78
11.76%-3
3.23%-3
-38.61%-14
-76.00%-4.4
-27.20%-3.18
-36.00%-3.4
-19.23%-3.1
2.88%-10.1
0.00%-2.5
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Total revenue 0007M07M0000
Operating revenue --0--0--0--7M--0--7M--0--0--0--0
Cost of revenue
Gross profit
Operating expense -32.52%21.95M-18.23%21.9M-3.32%23.71M57.72%112.24M41.77%28.4M71.86%32.53M64.09%26.78M54.45%24.52M30.19%71.16M42.05%20.03M
Selling and administrative expenses -35.08%5.71M-3.15%5.6M5.37%6.54M31.69%26.54M11.30%5.76M73.46%8.79M16.23%5.79M25.78%6.21M28.17%20.15M19.74%5.18M
-General and administrative expense -35.08%5.71M-3.15%5.6M5.37%6.54M31.69%26.54M11.30%5.76M73.46%8.79M16.23%5.79M25.78%6.21M28.17%20.15M19.74%5.18M
Research and development costs -31.58%16.24M-22.39%16.3M-6.26%17.17M68.00%85.7M52.38%22.64M71.27%23.74M85.08%21M67.38%18.32M31.01%51.01M51.92%14.86M
Operating profit 14.02%-21.95M18.23%-21.9M3.32%-23.71M-47.88%-105.24M-41.77%-28.4M-34.87%-25.53M-64.09%-26.78M-54.45%-24.52M-30.19%-71.16M-42.05%-20.03M
Net non-operating interest income expense -32.55%1.64M-25.85%1.84M-11.70%2.05M226.86%9.55M25.69%2.33M124.44%2.42M1,720.59%2.48M1,692.47%2.33M9,979.31%2.92M1,800.00%1.85M
Non-operating interest income -27.73%2.04M-21.81%2.24M-8.98%2.45M170.30%11.1M23.89%2.73M102.88%2.82M601.23%2.86M2,395.37%2.7M2,085.11%4.11M4,304.00%2.2M
Non-operating interest expense 1.77%403K4.16%401K8.11%400K30.80%1.55M14.33%399K27.74%396K41.54%385K45.67%370K645.28%1.19M119.50%349K
Other net income (expense) -1.48M-6.19M
Special income (charges) --0---1.48M-------6.19M---6.19M--0--0------0----
-Less:Restructuring and merger&acquisition --0--1.48M------6.19M--6.19M--0--0------0----
Income before tax 12.08%-20.31M11.36%-21.55M2.44%-21.66M-49.28%-101.87M-77.44%-32.26M-29.45%-23.1M-50.17%-24.31M-38.54%-22.2M-24.91%-68.24M-27.93%-18.18M
Income tax
Net income 12.08%-20.31M11.36%-21.55M2.44%-21.66M-49.28%-101.87M-77.44%-32.26M-29.45%-23.1M-50.17%-24.31M-38.54%-22.2M-24.91%-68.24M-27.93%-18.18M
Net income continuous Operations 12.08%-20.31M11.36%-21.55M2.44%-21.66M-49.28%-101.87M-77.44%-32.26M-29.45%-23.1M-50.17%-24.31M-38.54%-22.2M-24.91%-68.24M-27.93%-18.18M
Minority interest income
Net income attributable to the parent company 12.08%-20.31M11.36%-21.55M2.44%-21.66M-49.28%-101.87M-77.44%-32.26M-29.45%-23.1M-50.17%-24.31M-38.54%-22.2M-24.91%-68.24M-27.93%-18.18M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 12.08%-20.31M11.36%-21.55M2.44%-21.66M-49.28%-101.87M-77.44%-32.26M-29.45%-23.1M-50.17%-24.31M-38.54%-22.2M-24.91%-68.24M-27.93%-18.18M
Basic earnings per share 12.58%-2.7811.76%-33.23%-3-38.61%-14-76.00%-4.4-27.20%-3.18-36.00%-3.4-19.23%-3.12.88%-10.10.00%-2.5
Diluted earnings per share 12.58%-2.7811.76%-33.23%-3-38.61%-14-76.00%-4.4-27.20%-3.18-36.00%-3.4-19.23%-3.12.88%-10.10.00%-2.5
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--
Heat List
US
Overall
Symbol
Price
% Chg

No Data